Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers
Lara Petelin, Lucinda Hossack, Mary Shanahan, Gillian Mitchell, Danny Liew, Paul A. James, Alison H. Trainer
Topics & Concepts
MedicineCost effectivenessBreast cancerCost–benefit analysisOncologyGynecologyIntensive care medicineCancerInternal medicineRisk analysis (engineering)EcologyBiologyBRCA gene mutations in cancerHealth Systems, Economic Evaluations, Quality of LifePARP inhibition in cancer therapy